Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

NCT01740414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Opioid Abuse
Opioid Dependence

Interventions

DRUG: MN-166 (50 mg) First
DRUG: Placebo First

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]